Inogen, Inc. filed an 8-K on November 19, 2026, disclosing that Kevin R.M. Smith entered into a separation agreement and release with the company on November 16, 2026, and simultaneously resigned from its board of directors.

Key Highlights

  • Separation agreement signed: Kevin R.M. Smith and Inogen executed a separation agreement and release on November 16, 2026, following his employment end date of October 30, 2026.
  • Severance consistent with prior agreement: The company will provide severance benefits consistent with those in Mr. Smith's Employment and Severance Agreement, effective as of November 10, 2023, subject to specified conditions.
  • Prorated bonus eligibility: Mr. Smith is eligible to earn a prorated annual bonus for fiscal 2026 based on actual performance, according to the filing.
  • Equity vesting: Certain equity awards scheduled to vest on December 1, 2026, will vest under the terms of the Separation Agreement.
  • Board resignation: Mr. Smith resigned from the board of directors effective November 16, 2026, with the company stating the resignation was not the result of any disagreement relating to its operations, policies, or practices.
  • Board size reduced: Following Mr. Smith's resignation, the board reduced the authorized number of directors from nine to eight, effective November 17, 2026.

Details of Smith's Separation and Board Departure at Inogen

According to the filing, Mr. Smith's role as an officer and employee of Inogen, Inc. (NASDAQ:INGN) ended effective October 30, 2026, as previously reported in a Form 8-K filed November 5, 2026. The current filing discloses that the formal separation agreement and release was executed on November 16, 2026, formalizing the terms of his departure.

The Separation Agreement, filed as Exhibit 10.1, provides severance benefits to Mr. Smith subject to three conditions: his execution of the agreement, the agreement becoming effective, and his continued compliance with its terms. The company disclosed that the benefits are consistent with those outlined in Mr. Smith's Employment and Severance Agreement dated November 10, 2023. The filing also notes his eligibility for a prorated fiscal 2026 annual bonus based on actual performance, as well as the vesting of certain equity awards originally scheduled for December 1, 2026.

In connection with the separation, Mr. Smith also resigned from Inogen's board of directors on November 16, 2026. The filing states that "Mr. Smith's resignation was not the result of any disagreement with the Company relating to the Company's operations, policies or practices." The board then reduced its authorized director count from nine to eight, effective November 17, 2026. The filing was signed by Jason Richardson, Executive Vice President, Chief Financial Officer, and Treasurer.

What Was Disclosed

Inogen disclosed the terms of Kevin R.M. Smith's separation agreement, including severance benefits, prorated bonus eligibility, equity award vesting, and his resignation from the board, with the board subsequently reducing its authorized size from nine to eight directors.